The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes
- PMID: 10545478
- DOI: 10.1093/intimm/11.11.1745
The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes
Abstract
Previous studies indicated that signaling through lymphocyte activation gene-3 (LAG-3), a MHC class II ligand, induced by multivalent anti-receptor antibodies led to unresponsiveness to TCR stimulation. Here, lateral distribution of the LAG-3 molecules and its topological relationship (mutual proximity) to the TCR, CD8, CD4, and MHC class I and II molecules were studied in the plasma membrane of activated human T cells in co-capping experiments and conventional fluorescence microscopy. Following TCR engagement by either TCR-specific mAb or MHC-peptide complex recognition in T-B cell conjugates, LAG-3 was found to be specifically associated with the CD3-TCR complex. Similarly, following CD8 engagement LAG-3 and CD8 were co-distributed on the cell surface while only a low percentage of CD4-capped cells displayed LAG-3 co-caps. In addition, LAG-3 was found to be associated with MHC class II (i.e. DR, DP and DQ) and partially with MHC class I molecules. The supramolecular assemblies described here between LAG-3, CD3, CD8 and MHC class II molecules may result from an organization in raft microdomains, a phenomenon known to regulate early events of T cell activation.
Similar articles
-
T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.Eur J Cancer. 2001 Sep;37(13):1709-18. doi: 10.1016/s0959-8049(01)00184-8. Eur J Cancer. 2001. PMID: 11527700
-
Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes.Eur J Immunol. 1994 Dec;24(12):3216-21. doi: 10.1002/eji.1830241246. Eur J Immunol. 1994. PMID: 7805750
-
LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathway.Eur J Immunol. 2001 Oct;31(10):2885-91. doi: 10.1002/1521-4141(2001010)31:10<2885::aid-immu2885>3.0.co;2-2. Eur J Immunol. 2001. PMID: 11592063
-
The roles of CD4 and CD8 in T cell activation.Semin Immunol. 1991 May;3(3):133-41. Semin Immunol. 1991. PMID: 1909592 Review.
-
Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.Immunol Rev. 1989 Jun;109:119-41. doi: 10.1111/j.1600-065x.1989.tb00022.x. Immunol Rev. 1989. PMID: 2527803 Review.
Cited by
-
Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients.Oncotarget. 2016 Jul 12;7(28):43604-43615. doi: 10.18632/oncotarget.9871. Oncotarget. 2016. PMID: 27283895 Free PMC article.
-
LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.J Immunol. 2016 Jul 1;197(1):119-27. doi: 10.4049/jimmunol.1401594. Epub 2016 May 20. J Immunol. 2016. PMID: 27206765 Free PMC article.
-
Immune Checkpoints in Recurrent Pregnancy Loss: New Insights into a Detrimental and Elusive Disorder.Int J Mol Sci. 2023 Aug 22;24(17):13071. doi: 10.3390/ijms241713071. Int J Mol Sci. 2023. PMID: 37685876 Free PMC article.
-
Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease.Front Immunol. 2017 May 3;8:513. doi: 10.3389/fimmu.2017.00513. eCollection 2017. Front Immunol. 2017. PMID: 28515726 Free PMC article.
-
Role of Next Generation Immune Checkpoint Inhibitor (ICI) Therapy in Philadelphia Negative Classic Myeloproliferative Neoplasm (MPN): Review of the Literature.Int J Mol Sci. 2023 Aug 7;24(15):12502. doi: 10.3390/ijms241512502. Int J Mol Sci. 2023. PMID: 37569880 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous